Lipopolysaccharide Binding Protein (LBP) Peptid
LBP
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle LBP Produkte
- LBP (Lipopolysaccharide Binding Protein (LBP))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- FLKPGKVKVE LKESKVGLFN AELLEALLNY YILNTFYPKF NDKLAEGFPL
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LBP antibody,
Alternative Names: LBP control peptide, LBP antibody Blocking Peptide, Anti-LBP Blocking Peptide, Lipopolysaccharide Binding Protein Blocking Peptide, MGC22233 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- LBP (Lipopolysaccharide Binding Protein (LBP))
- Hintergrund
- LBP is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI), the protein binds LPS and interacts with the CD14 receptor, probably playing a role in regulating LPS-dependent monocyte responses.
- Molekulargewicht
- 51 kDa
-
Sie sind hier:
